Pain-relief specialist Afferent Pharmaceuticals raises a soothing $23m | AltAssets Private Equity News

Subscribe today

Advanced
Search

Pain-relief specialist Afferent Pharmaceuticals raises a soothing $23m

16 Dec 2009

Afferent Pharmaceuticals, a California-based developer of dugs for chronic pain, has raised $23m in Series A funding. Third Rock Ventures and Pappas Ventures co-led the round, and were joined by Domain Associates and New Leaf Venture Partners.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.